DBV Technologies S.A.
DBVTNASDAQHealthcare● Active
$16.00
$-0.59(-3.56%)
Market Cap$382747824
P/E Ratio—
52W High$26.185
52W Low$8.3
DBV Technologies S.A. (DBVT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
DBVT · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 30, 2026EPS Actual
-$0.56
Est. -$0.14 · -300.0%
Revenue
$0.00B
Est. $0.00B · -4.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 30, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
DBVT reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | -$0.12 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | Apr 30, 2026 | -$0.14 | -$0.56 | -300.0% | $0.00B | $0.00B | -4.9% |
| ▲ Q1 FY2026 | Mar 27, 2026 | -$1.30 | -$1.15 | +11.5% | $0.00B | $0.00B | -60.5% |
| ▲ Q4 FY2025 | Oct 28, 2025 | -$1.45 | -$1.20 | +17.2% | $0.00B | $0.00B | +204.5% |
| ▼ Q3 FY2025 | Jul 29, 2025 | -$0.21 | -$1.55 | -638.1% | $0.00B | $0.00B | +129.6% |
| ▼ Q2 FY2025 | Apr 30, 2025 | -$0.24 | -$0.26 | -8.3% | $0.00B | $0.00B | +81.3% |
| ▲ Q1 FY2025 | Mar 27, 2025 | -$2.00 | -$1.20 | +40.0% | $0.00B | $0.00B | +19.5% |
| ▲ Q4 FY2024 | Nov 6, 2024 | -$1.90 | -$0.80 | +57.9% | $0.00B | $0.00B | +13.0% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
-$0.12
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 30, 2026Miss
EPS Actual
-$0.56
EPS Est.
-$0.14
EPS Surpr.
-300.0%
Revenue
$0.00B
Q1 FY2026
Mar 27, 2026Beat
EPS Actual
-$1.15
EPS Est.
-$1.30
EPS Surpr.
+11.5%
Revenue
$0.00B
Q4 FY2025
Oct 28, 2025Beat
EPS Actual
-$1.20
EPS Est.
-$1.45
EPS Surpr.
+17.2%
Revenue
$0.00B
Q3 FY2025
Jul 29, 2025Miss
EPS Actual
-$1.55
EPS Est.
-$0.21
EPS Surpr.
-638.1%
Revenue
$0.00B
Q2 FY2025
Apr 30, 2025Miss
EPS Actual
-$0.26
EPS Est.
-$0.24
EPS Surpr.
-8.3%
Revenue
$0.00B
Q1 FY2025
Mar 27, 2025Beat
EPS Actual
-$1.20
EPS Est.
-$2.00
EPS Surpr.
+40.0%
Revenue
$0.00B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
-$0.80
EPS Est.
-$1.90
EPS Surpr.
+57.9%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.06 | $-0.06 | $-0.06 | 1 |
| Q3 FY2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q2 FY2027 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Q1 FY2027 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Q4 FY2026 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Q3 FY2026 | $-0.13 | $-0.13 | $-0.13 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | Apr 30, 2026 | -300.0% | $20.30 | $21.00 | +3.45% |
| ▲ Q1 FY2026 | Mar 27, 2026 | +11.5% | $20.21 | $20.00 | -1.04% |
| ▲ Q4 FY2025 | Oct 28, 2025 | +17.2% | $15.99 | $15.55 | -2.75% |
| ▼ Q3 FY2025 | Jul 29, 2025 | -638.1% | $9.73 | $9.80 | +0.72% |
| ▼ Q2 FY2025 | Apr 30, 2025 | -8.3% | $9.08 | $9.01 | -0.77% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +40.0% | $4.05 | $3.91 | -3.46% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +57.9% | $4.75 | $4.83 | +1.68% |
| ▼ Q3 FY2024 | Jul 30, 2024 | -30.8% | $5.75 | $5.95 | +3.48% |
Q2 FY2026+3.45%
Report Date
Apr 30, 2026
EPS Beat/Miss
-300.0%
Price Before
$20.30
Price After
$21.00
Q1 FY2026-1.04%
Report Date
Mar 27, 2026
EPS Beat/Miss
+11.5%
Price Before
$20.21
Price After
$20.00
Q4 FY2025-2.75%
Report Date
Oct 28, 2025
EPS Beat/Miss
+17.2%
Price Before
$15.99
Price After
$15.55
Q3 FY2025+0.72%
Report Date
Jul 29, 2025
EPS Beat/Miss
-638.1%
Price Before
$9.73
Price After
$9.80
Q2 FY2025-0.77%
Report Date
Apr 30, 2025
EPS Beat/Miss
-8.3%
Price Before
$9.08
Price After
$9.01
Q1 FY2025-3.46%
Report Date
Mar 27, 2025
EPS Beat/Miss
+40.0%
Price Before
$4.05
Price After
$3.91
Q4 FY2024+1.68%
Report Date
Nov 6, 2024
EPS Beat/Miss
+57.9%
Price Before
$4.75
Price After
$4.83
Q3 FY2024+3.48%
Report Date
Jul 30, 2024
EPS Beat/Miss
-30.8%
Price Before
$5.75
Price After
$5.95
Avg Beat Reaction-1.39%
Avg Miss Reaction+1.72%
Beat Rate4 / 8 quarters
Largest Move+3.48% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: DBVT ends December
DBV Technologies S.A. (DBVT) most recently reported earnings on April 30, 2026 for Q2 FY2026, posting EPS of $-0.56 — missing the analyst consensus of $-0.14 by -300.0%. The next DBVT earnings date is expected around September 1, 2026.
Each quarter, investors track DBVT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DBVT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DBVT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
DBVT earnings · 5 questionsDBV Technologies S.A.'s next earnings report is expected around September 1, 2026. DBVT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DBVT historically reports after market close (AMC).
DBVT earnings datewhen is DBVT earningsDBVT next earnings datewhen does DBVT report earningsDBVT earnings calendar
▸ Source: FMP · DBV Technologies S.A. SEC filings · US GAAP · DBV Technologies S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026